Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Prospective genome and transcriptome sequencing in advanced-stage neuroendocrine neoplasms (2018) Apostolidis L, Kreutzfeldt S, Oles M, Gieldon L, Heining C, Horak P, Hutter B, et al. Conference contribution COMPETE trial: Peptide receptor radionuclide therapy (PRRT) with 177Lu-edotreotide vs. everolimus in progressive GEP-NET (2018) Pavel ME, Rinke A, Baum RP Conference contribution Gut⁻Liver Axis: How Do Gut Bacteria Influence the Liver? (2018) Konturek PC, Harsch IA, Konturek K, Schink M, Konturek T, Neurath M, Zopf Y Journal article, Review article Therapeutic modulation of the bile acid pool by cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice (2018) Chevre R, Trigueros-Motos L, Castano D, Chua T, Corliano M, Patankar J, Sng L, et al. Journal article Interferon-gamma triggers an anti-tumorigenic chain reaction in the tumor vessels of colorectal carcinoma (2018) Stürzl M, Langer V, Regensburger D, Tenkerian C, Klingler A, Waldner M, Becker C, et al. Conference contribution Loss of IFN-gamma pathway gene expression in tumor cells as mechanism of immune escape of colorectal carcinoma (2018) Britzen-Laurent N, Straube J, Waldner M, Becker C, Croner R, Pilarsky C, Merkel S, Stürzl M Conference contribution Treatment efficacyand safety of seladelpar, a selective peroxisome proliferator-activated receptor delta agonist, in primary biliary cholangitis patients: 12-and 26-week analysis from an ongoing international, randomized, dose raging phase 2 study (2018) Hirschfield G, Boudes P, Bowlus C, Gitlin N, Michael G, Harrison S, Gordon SC, et al. Conference contribution International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease (2018) Williamson K, Lytvyak E, Kremer A, De Krijger M, Trivedi P, Estes D, Yu L, et al. Conference contribution Long-Term Obeticholic Acid (OCA) treatment associated with reversal or stabilization of fibrosis/cirrhosis in patients with Primary Biliary Cholangitis (PBC) (2018) Bowlus C, Pockros P, Kremer A, Pares A, Forman L, Drenth JP, Ryder S, et al. Conference contribution Pruritus strongly reduces quality of life in PBC patients - real life data from a large national survey (2018) Hönig S, Herder B, Kautz A, Trautwein C, Kremer A Conference contribution